Non-small cell lung cancer, adenocarcinoma

PheWeb

HLP_C3_NSCLC_ADENO

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Cancer registry: Topography ICD-O-3 C34

Cancer registry: Morphology ICD-O-3 8140

Cancer registry: Behaviour codes 3

4139

Check pre-conditions, main-only, mode, ICD version None

1130

Check minimum number of events None

1130

Include endpoints None

1130

HLP_C3_NSCLC_ADENO

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Non-small cell lung cancer, adenocarcinoma based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	-	-	-
Unadjusted prevalence (%)	-	-	-
Mean age at first event (years)	-	-	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: HLP_C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Non-small cell lung cancer, adenocarcinoma
after Non-small cell lung cancer, adenocarcinoma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Non-small cell lung cancer, adenocarcinoma

↥